Cell Therapy
From Research to Clinical Trials to Commercialization: Advancing CGT with Frozen Cellular Starting Materials
Dominic Mancini
OrganaBio
PAO-01-25-CL-13Jan 28, 2025
Allogeneic Cell Therapy Logistics
Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement
Joy Aho, Ph.D.
Be The Match BioTherapies
PAO-06-23-CL-06Jun 27, 2023
Cell Therapy
Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-23-NI-01Jan 31, 2023
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Bryan Kobel
TC Biopharm
PAO-07-022-CL-03Aug 09, 2022
Cell Therapy
Expanding Access to Cell Therapies with a Patient-Centric Focus
Amy L. Ronneberg
Be The Match BioTherapies
PAO-02-022-CL-12Mar 12, 2022
Cell Therapy
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Chris McClain
Be The Match BioTherapies
PAO-09-21-CL-04Sep 09, 2021
Cell Therapy
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
Catalent
PAO-12-20-CL-01Dec 16, 2020